RED CELLS, IRON, AND ERYTHROPOIESIS Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine

نویسندگان

  • Donald Lavelle
  • Kestis Vaitkus
  • Yonghua Ling
  • Maria A. Ruiz
  • Reda Mahfouz
  • Kwok Peng Ng
  • Soledad Negrotto
  • Nicola Smith
  • Pramod Terse
  • Kory J. Engelke
  • Joseph Covey
  • Kenneth K. Chan
  • Joseph DeSimone
  • Yogen Saunthararajah
چکیده

1Department of Medicine, University of Illinois at Chicago, Chicago, IL; 2Jesse Brown VA Medical Center, Chicago, IL; 3College of Pharmacy, The Ohio State University, Columbus, OH; 4Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH; 5Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; 6Avanza Laboratories, Gaithersburg, MD; and 7Hematologic Malignancies and Blood Disorders, Cleveland Clinic, Cleveland, OH

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Pharmacokinetics and Pharmacodynamics of Iron Preparations

Standard approaches are not appropriate when assessing pharmacokinetics of iron supplements due to the ubiquity of endogenous iron, its compartmentalized sites of action, and the complexity of the iron metabolism. The primary site of action of iron is the erythrocyte, and, in contrast to conventional drugs, no drug-receptor interaction takes place. Notably, the process of erythropoiesis, i.e., ...

متن کامل

Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects

BACKGROUND AND PURPOSE Anaemia of chronic disease is characterized by impaired erythropoiesis due to functional iron deficiency, often caused by excessive hepcidin. Lexaptepid pegol, a pegylated structured l-oligoribonucleotide, binds and inactivates hepcidin. EXPERIMENTAL APPROACH We conducted a placebo-controlled study on the safety, pharmacokinetics and pharmacodynamics of lexaptepid after...

متن کامل

Recent advances in myelodysplasia: update from 2011 ASH annual meeting

Significant progresses have been made in genetic research in MDS. Through RNA interference technology, knockdown of RPS14 recapitulated the pathological process of decreased erythropoiesis [1]. Transgenic expression of RPS14 in 5qMDS cells rescued the phenotype of insufficient erythropoiesis. This strongly suggests that haploinsufficiency of RPS14 is one of the molecular mechanisms in the patho...

متن کامل

مروری بر تالاسمی و عوارض ناشی از آن

Thalassemia is a highly progressive hemolytic anemia with different levels of complexity in patients. In thalassemia, reduced level of synthesis of hemoglobin chains results in an imbalanced production of alpha and beta globin chains, and sedimentation of unpaired chains inside red blood cells is the beginning of complications among thalassemia patients. Nowadays compatible blood transfusion is...

متن کامل

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

BACKGROUND Hepcidin plays a central role in iron homeostasis and erythropoiesis. Neutralizing hepcidin with a monoclonal antibody (mAb) may prevent ferroportin internalization, restore iron efflux from cells, and allow transferrin-mediated iron transport to the bone marrow. This multicenter, phase 1 study evaluated the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of a full...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012